Changes in both biomarkers stratified across baseline values.
When changes in logCA125 were stratified across the baseline values of CA125 (< 23 vs. ≥ 23 U/ml), we identified a greater reduction of logCA125 in those with CA125 at baseline ≥ 23 U/ml (omnibus p-value between treatments = 0.002), as is shown in Fig. Changes in logCA125 (